Industry News
Biotechnology Industry News
Insurer plans $4B investment blitz to add lab space outside of U.S. biotech hot spots
Insurer plans $4B investment blitz to add lab space outside of U.S. biotech hot spots ntaylor Wed, 05/25/2022 - 04:22
ASCO: I-Mab, Junshi’s cancer combo performs best as a first-line NSCLC treatment, with signals for CD73 as a biomarker
ASCO: I-Mab, Junshi's cancer combo performs best as a first-line NSCLC treatment, with signals for CD73 as a biomarker mbayer Tue, 05/24/2022 - 17:40
ASCO: J&J’s multiple myeloma toolkit expands with bispecifics data
ASCO: J&J's multiple myeloma toolkit expands with bispecifics data aarmstrong Tue, 05/24/2022 - 12:28
CSL Behring gene therapy makes comeback after hold for FDA priority review
CSL Behring gene therapy makes comeback after hold for FDA priority review gmasson Tue, 05/24/2022 - 10:29
Genocea closes up shop after failing to find a buyer, delists from Nasdaq
Genocea closes up shop after failing to find a buyer, delists from Nasdaq mbayer Tue, 05/24/2022 - 10:18
Manufacturing concerns sideline INmune’s US Alzheimer’s trial
Manufacturing concerns sideline INmune's US Alzheimer's trial aarmstrong Tue, 05/24/2022 - 09:46
Supply chain challenges upend Caladrius’ coronary artery disease trial
Supply chain challenges upend Caladrius' coronary artery disease trial aarmstrong Tue, 05/24/2022 - 09:24
When will biotech markets get better? BridgeBio fears they may stay ‘pretty bad’ until 2024
When will biotech markets get better? BridgeBio fears they may stay 'pretty bad' until 2024 ntaylor Tue, 05/24/2022 - 08:39
Boing! SpringWorks’ stock jumps as phase 3 tumor trial hits goal
Boing! SpringWorks' stock jumps as phase 3 tumor trial hits goal ntaylor Tue, 05/24/2022 - 07:23
Moderna tunes vaccine platform to next potential viral threat: monkeypox
Moderna tunes vaccine platform to next potential viral threat: monkeypox mbayer Mon, 05/23/2022 - 16:33
After COVID and new global disruptions, Eli Lilly does victory lap with UC data
After COVID and new global disruptions, Eli Lilly does victory lap with UC data aarmstrong Mon, 05/23/2022 - 14:27
Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spin out preps FDA filing
Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spin out preps FDA filing gmasson Mon, 05/23/2022 - 10:54
Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spinout preps FDA filing
Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spinout preps FDA filing gmasson Mon, 05/23/2022 - 10:54
Biohaven flunks first clinical test for rare disease drug post-Pfizer sell-off
Biohaven flunks first clinical test for rare disease drug post-Pfizer sell-off mbayer Mon, 05/23/2022 - 10:16
Chasing Lilly and Pfizer, Concert’s JAK inhibitor hits high notes in phase 3 alopecia trial
Chasing Lilly and Pfizer, Concert's JAK inhibitor hits high notes in phase 3 alopecia trial ntaylor Mon, 05/23/2022 - 08:41
J&J’s $230M blood pressure bet hits phase 3 endpoint, but questions linger about blockbuster potential
J&J's $230M blood pressure bet hits phase 3 endpoint, but questions linger about blockbuster potential ntaylor Mon, 05/23/2022 - 05:29
Zymeworks rejects All Blue’s $773M offer as an ‘opportunistic’ public attack
Zymeworks rejects All Blue's $773M offer as an 'opportunistic' public attack aarmstrong Fri, 05/20/2022 - 10:53
Not an ‘excellent outcome’ for Athersys stock as stem cell therapy misses endpoint in Japanese trial
Not an 'excellent outcome' for Athersys stock as stem cell therapy misses endpoint in Japanese trial jwaldron Fri, 05/20/2022 - 09:45
100% overall survival data for gene therapy fuel Rocket for flight to regulators
100% overall survival data for gene therapy fuel Rocket for flight to regulators aarmstrong Fri, 05/20/2022 - 09:41
Terremoto spells out plan to expand covalent drug alphabet with $75M funding
Terremoto spells out plan to expand covalent drug alphabet with $75M funding jwaldron Fri, 05/20/2022 - 07:33